Biotech acquisitions by big pharma: why and what is next

  • Malik N
  • 41

    Readers

    Mendeley users who have this article in their library.
  • 10

    Citations

    Citations of this article.

Abstract

Leading pharmaceutical companies are increasingly making biotech acquisitions to help them refill their pipelines, but what makes a good acquisition target and what will be the impact of the present financial crisis on deals. © 2009 Elsevier Ltd. All rights reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Nafees N. Malik

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free